BioPharma Dive - Latest News

Kymera adds Gilead as research partner, while advancing new candidate with Sanofi

The biotech will work on molecular glue degraders with Gilead in a new deal. Existing partner Sanofi changed its focus to a new drug prospect, meanwhile.

Jun 25, 2025 - 17:45
 0
Kymera adds Gilead as research partner, while advancing new candidate with Sanofi

The biotech will work on molecular glue degraders with Gilead in a new deal. Existing partner Sanofi changed its focus to a new drug prospect, meanwhile.

Read More

Tags:

Previous Article

J&J launches AI surgery funding competition with Nvidia, AWS

Next Article

CDC vaccine advisory committee to review long-approved immunizations

Related Posts

FDA delays approval decision for Biohaven rare disease drug

FDA delays approval decision for Biohaven rare disease ...

May 15, 2025  0

Gene therapy faces fresh uncertainty as two more top FDA officials depart

Gene therapy faces fresh uncertainty as two more top FD...

Jun 20, 2025  0

SpliceBio lands $135M for a new kind of eye gene therapy

SpliceBio lands $135M for a new kind of eye gene therapy

Jun 11, 2025  0